Open AccessAccuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
Author(s) -
Sebastian Palmqvist,
Henrik Zetterberg,
Kaj Blennow,
Susanna Vestberg,
Ulf Andréasson,
David J. Brooks,
Rikard Owenius,
Douglas Hägerström,
Per Wollmer,
Lennart Minthon,
Oskar Hansson
Publication year - 2014
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2014.1358
Subject(s) - cerebrospinal fluid , medicine , memory clinic , odds ratio , receiver operating characteristic , pathology , dementia , alzheimer's disease , cohort , amyloid (mycology) , positron emission tomography , gastroenterology , nuclear medicine , disease
Before adding cerebrospinal fluid (CSF) biomarkers to the diagnostic workup of Alzheimer disease, it needs to be determined whether CSF biomarkers analyzed in routine clinical practice can reliably predict cortical β-amyloid (Aβ) deposition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom